5th International Congress on Psycpharmacology

October 30, 2013
Wednesday
October 31, 2013
Thursday
November 1, 2013
Friday
November 2, 2013
Saturday
November 3, 2013
Sunday

October 30, 2013 - Wednesday

08:30-22:00 Registration
08:30-12:30 HALL A
Course-1:
Psychoeducation in Bipolar Disorders
Ian Jones (UK) (English)
John Tredget (UK) (English)
14:30-15:00 HALL A
OPENING
15:00-16:00

HALL A
Keynote Address
DSM-5, how do the changes affect decision-making in psychopharmacology?

David Osser (USA)

16:00-16:30 COFFEE BREAK
16:30-18:30

HALL A
JOINT SYMPOSIUM-1: ICP - TAP
New Perspectives in Perinatal Psychiatry

Discussant Moderators:
Nazan Aydin (Turkey) -
Ian Jones (UK)

Does childbirth cause postpartum psychiatric disorders? A natural experiment based on outcomes after in-vitro fertility treatment
Trine Munk Olsen (Denmark)

Recent clinical and genetic research findings in perinatal psychiatry
Ian Jones (UK)

How to build efficient and sustainable community networks for new families
Jane Honikman (USA)

Delivery related post traumatic stress disorder
Onder Kavakci (Turkey)

Interpersonal psychotherapy in perinatal period
Oguz Omay (France) -
Scott Stuart (USA)

HALL B
Symposium-1
Current Data Towards Developmental Defects

Discussant Moderators:
Eyup Ercan (Turkey) -
Aynur Akay (Turkey)

Importance of inpatient treatment on pervasive developmental disorder
Ozgur Oner (Turkey)

What happens to children with autistic spectrum disorders in adulthood?
Murat Coskun (Turkey)

Innovations of pharmacological treatments for problem behaviors of autistic spectrum disorder
Ali Sarper Taskiran (Turkey)

Pharmacotherapy for aggressive behavior in children and adolescents with mental retardation
Fatih Ceylan (Turkey)

HALL C
JOINT SYMPOSIUM- 2: Bosna Herzeginova
From Depression to dependency: Current problems in psychiatry

Dicussant Moderators:
Dragan Babic (Bosnia-Herzegovina) -
Ęsmail Ak (Turkey)

Complementary medicine in antidepressant treatment
Dragan Babic (Bosnia-Herzegovina)

Type of traumatic experience and depression
Marija B.Radmanovic (Bosnia-Herzegovina)

Obsessive compulsive disorder and schizophrenia in adolescents
Abdulah Kuçukaliç (Bosnia-Herzegovina)

Quality of life of heroin addicts and their family members improved during the treatment of opiate dependence with buprenorphine/naloxon (suboxone)
Izet Pajevic (Bosnia-Herzegovina)

Treatment for opiate dependence with buprenorphine/naloxone (suboxone) method as prevention of social exclusion of adolescents – Tuzla model
M. Hasanovic (Bosnia-Herzegovina)

18:30-19:00 COFFEE BREAK
19:00-21:00

HALL A
Symposium-2:
Insidious threat: new generation addictive substances

Discussant Moderators:
Ilhan Yargic (Turkey) -
Izet Pajevic (Bosnia-Herzegovina)

Synthetic cannabinoids: more dangerous than cannabis
Ilhan Yargic (Turkey)

Buprenorphine: Its abuse and ways of prevention
Cuneyt Evren (Turkey)

Quetiapine abuse, myth or truth?
Murat Kuloglu (Turkey)

New limits on alcohol use, what will they bring?
Nesrin Dilbaz (Turkey)

HALL B
Symposium-3:
Selection and Evaluation of Treatment in Child and Adolescent Psychopharmacology

Discussant Moderators:
Mucahit Ozturk (Turkey) -
Yasemen Isik (Turkey)


The importance of therapeutic drug monitoring in child and adolescent psychiatry
Ozgur Yorbik (Turkey)

Childhood psychiatric disorders, neuroimaging and biomarkers
Onur B. Dursun (Turkey)

Factors to be considered in the treatment of psychopathology in preschool children
Cem Gokcen (Turkey)

Are psychotherapeutic approaches always superior to psychopharmacological treatments in childhood?
Tayyip Kadak (Turkey)

Course-2
EMDR

Onder Kavakci (Turkey) (Turkish)
Course-3
Beyond Talk, into Action: Working with Users' Associations in Perinatal Psychiatry

Jane Honikman (USA) (English) - Oguz Omay (France) (English)

Turkish - English; English-Turkish simultane translation